Home › Business & Economics › Bad Blood: Secrets and Lies in a Silicon Valley Startup

Bad Blood: Secrets and Lies in a Silicon Valley Startup

by John Carreyrou

A startup’s promise under scrutiny

Regular price $18.34 USD
Regular price $30.57 USD Sale price $18.34 USD
Save 40%

Paperback New

Delivery to your door
In stock·Dispatches in 1–2 business days
Standard shipping* from $4.35
Standard shipping transit* 5–8 business days after dispatch

Faster options are available.

Rates and delivery estimates depend on your destination and item quantity. Estimates are informational only; the final shipping method and rate are selected at checkout.

Secure checkout
American Express Apple Pay DiscoverGoogle Pay Mastercard PayPalVisa
30-day eligible returns Returns & refunds policy

AlbakiReads Editorial

A startup’s promise under scrutiny

John Carreyrou’s account traces Theranos from its headline-making promise of blood testing from a single drop to the growing gap between that claim and the technology’s performance. The story brings together Elizabeth Holmes’s rise, the investors who backed the company, reported risks to patients, and efforts to suppress internal and journalistic doubts. Its focus on entrepreneurship is inseparable from questions of corporate accountability and the consequences of presenting unproven technology as a medical breakthrough. A new afterword covers Holmes’s trial and sentencing, extending the account beyond the company’s collapse.

Good fit for readers who enjoy

  • Readers interested in Silicon Valley companies and startup culture.
  • Readers seeking reported accounts of corporate misconduct and accountability.
  • Readers interested in the intersection of entrepreneurship and medical technology.

Themes

Entrepreneurship and ambitionCorporate accountabilityMedical technology and patient riskSilencing dissent

Based on publisher information and book metadata.

Book overview

NATIONAL BESTSELLER - The gripping story of Elizabeth Holmes and Theranos--one of the biggest corporate frauds in history--a tale of ambition and hubris set amid the bold promises of Silicon Valley, rigorously reported by the prize-winning journalist. With a new Afterword covering her trial and sentencing, bringing the story to a close.

"Chilling ... Reads like a thriller ... Carreyrou tells [the Theranos story] virtually to perfection." --The New York Times Book Review


In 2014, Theranos founder and CEO Elizabeth Holmes was widely seen as the next Steve Jobs: a brilliant Stanford dropout whose startup "unicorn" promised to revolutionize the medical industry with its breakthrough device, which performed the whole range of laboratory tests from a single drop of blood. Backed by investors such as Larry Ellison and Tim Draper, Theranos sold shares in a fundraising round that valued the company at more than $9 billion, putting Holmes's worth at an estimated $4.5 billion. There was just one problem: The technology didn't work. Erroneous results put patients in danger, leading to misdiagnoses and unnecessary treatments. All the while, Holmes and her partner, Sunny Balwani, worked to silence anyone who voiced misgivings--from journalists to their own employees.
Shipping & returnsShipping options, delivery timing, and our return policy.

In-stock items normally dispatch within 1–2 business days. The ZIP-code estimator on this page is informational only; the final shipping method, price, and availability are confirmed at checkout for your full order.

For the initial delivery estimate we use these transit windows after dispatch: Standard 5–8 business days, Expedited 2–4 business days, and Priority 1–2 business days. Holiday delays are not included.

Eligible items can be returned within 30 days in accordance with our return policy.

Customer reviews